Related references
Note: Only part of the references are listed.
Article
Endocrinology & Metabolism
Mikiko Watanabe et al.
Summary: Variables such as increased waist circumference, smoking, hypertension, and longer time elapsed since vaccination were associated with lower antibody titres following COVID-19 mRNA vaccination. This suggests that individuals with central obesity, hypertension, and smoking may benefit from earlier vaccine boosters or different vaccination schedules to ensure adequate immune response.
DIABETES-METABOLISM RESEARCH AND REVIEWS
(2022)
Article
Medicine, Research & Experimental
Magali Noval Rivas et al.
Summary: In this study of healthcare workers, those with a history of BCG vaccination had lower seroprevalence of anti-SARS-CoV-2 IgG and reported fewer COVID-19-related symptoms compared to those without BCG vaccination. This suggests a potential protective effect of BCG vaccination against SARS-CoV-2 infection, warranting further large-scale clinical trials for confirmation.
JOURNAL OF CLINICAL INVESTIGATION
(2021)
Letter
Medicine, General & Internal
Priyanka et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
(2021)
Article
Multidisciplinary Sciences
Jennifer M. Dan et al.
Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.
Article
Multidisciplinary Sciences
Kate M. Bubar et al.
Summary: The study found that prioritizing the vaccine for adults aged 20 to 49 can minimize the number of cases, while prioritizing the vaccine for adults over 60 can minimize mortality and years of life lost. Redirecting vaccine doses to seronegative individuals through individual-level serological tests can improve the impact of each dose.
Article
Hematology
Jian Mao et al.
Summary: Hematologic changes in recovered COVID-19 patients are associated with disease severity and clinical outcomes, suggesting the need for further exploration of underlying mechanisms.
ANNALS OF HEMATOLOGY
(2021)
Review
Immunology
S. C. Jordan
Summary: This paper summarizes the unknown factors affecting the severity of COVID-19 and protective immunity, investigates immune responses, treatment methods, and vaccine efficacy. It also explores the long-term effects on immune responses in recovering patients.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
(2021)
Article
Health Care Sciences & Services
Wanfa Dai et al.
Summary: The study aimed to construct an efficient model for early identification and differentiation of COVID-19 from CAP using clinical laboratory indicators, achieving high performance in COVID-19 prediction with machine learning algorithms.
JOURNAL OF MEDICAL INTERNET RESEARCH
(2021)
Letter
Medicine, General & Internal
Maria Prendecki et al.
Letter
Medicine, General & Internal
Florian Krammer et al.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Multidisciplinary Sciences
Stephane Marot et al.
Summary: This study found that SARS-CoV-2 infection can induce neutralizing antibody response correlated with antibody levels, but this neutralizing activity declines after two months post-disease onset, suggesting the need for maintaining infection prevention measures and considering periodic vaccination boosts.
NATURE COMMUNICATIONS
(2021)
Article
Multidisciplinary Sciences
Colin Pawlowski et al.
Summary: Clinical studies are being conducted to evaluate the potential of existing vaccines in providing protection against SARS-CoV-2 through trained immunity. Analysis of immunization records from 137,037 individuals who underwent SARS-CoV-2 PCR tests revealed associations between various vaccines and decreased infection rates, with a significant reduction among black individuals who received the PCV13 vaccine.
SCIENTIFIC REPORTS
(2021)
Article
Public, Environmental & Occupational Health
Mostafa M. Khodeir et al.
Summary: This study conducted a meta-analysis on different biomarkers to predict the progression of COVID-19 from mild to severe cases. It found that certain biomarkers and risk factors, such as C-reactive protein, interleukin-6, LDH, neutrophil, D-dimer, creatinine, AST, cortisol, age, hypertension, diabetes, and chronic obstructive lung diseases, were significantly correlated with the severity of COVID-19 and its progression. More studies are needed to establish clearer threshold values for predicting progression and guiding proper treatment.
JOURNAL OF INFECTION AND PUBLIC HEALTH
(2021)
Article
Immunology
Sridhar Chilimuri et al.
Summary: Vaccines play a crucial role in ending the COVID-19 pandemic, but their safety and efficacy in multiple sclerosis patients receiving immunosuppressive therapies is not well-documented. Patients on B cell depleting therapy like ocrelizumab show a weakened vaccine response.
Editorial Material
Immunology
David H. Canaday et al.
Summary: After receiving the BNT162b2 messenger RNA vaccine, nursing home residents had antibody neutralization titers one-quarter of healthcare workers who were naive to SARS-CoV-2.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Immunology
Mei Zhou et al.
Summary: The study found that inflammation and vascular injury persisted in COVID-19 patients 3 months after discharge, and were closely correlated with abnormal clinical features, especially in severe patients. Immune cell levels had returned to normal levels and were not significantly correlated with abnormal clinical features.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Review
Sport Sciences
Sebastien F. M. Chastin et al.
Summary: Regular physical activity is associated with reduced risk of community-acquired infectious diseases and mortality, enhances the immune system's first line of defense, and improves the efficacy of vaccination.
Review
Immunology
Ali Pormohammad et al.
Summary: This study systematically reviewed the clinical features of COVID-19 vaccines in clinical trials, finding that mRNA-based and adenovirus-vectored vaccines exhibited different efficacy and side effect profiles. Both types of vaccines showed high efficacy after the first and second doses, with mRNA-based vaccines having higher reported side effects.
Article
Immunology
Chiara Di Resta et al.
Summary: The study demonstrates the impact of gender on COVID-19 vaccination coverage, with females showing higher antibody titers but experiencing more frequent side effects. Therefore, evaluating gender factors is crucial for vaccination strategies.
Review
Infectious Diseases
Ilker Kayi et al.
Summary: The study found a SARS-CoV-2 seroprevalence rate of 8% among HCWs in 2020, before vaccinations started, with higher rates observed in male HCWs, HCWs from ethnic minorities, those with high exposure, and those exposed to the virus outside healthcare settings.
CLINICAL MICROBIOLOGY AND INFECTION
(2021)
Article
Medicine, General & Internal
Jose F. Varona et al.
Summary: This study evaluated the kinetics of antibodies against SARS-CoV-2 in healthcare workers over a period of 9 months. Most participants remained seropositive, but there was a significant decline in antibody titers. Two distinct antibody dynamic profiles were observed: declining and stable. Factors associated with longer durability of antibodies included symptomatic infection and higher exposure to COVID-19 patients.
EUROPEAN JOURNAL OF INTERNAL MEDICINE
(2021)
Article
Multidisciplinary Sciences
Mari E. K. Niemi et al.
Summary: The genetic make-up of an individual plays a role in susceptibility and response to viral infections. A global network of researchers identified 13 significant genetic loci associated with SARS-CoV-2 infection and severe COVID-19 cases. Mendelian randomization analyses suggest a causal role for smoking and body-mass index in severe COVID-19. Collaboration among human genetics researchers has allowed for the discovery of novel host genetic factors linked to COVID-19.
Review
Infectious Diseases
Shin Jie Yong
Summary: Long COVID or post-COVID-19 syndrome is a poorly understood condition that affects survivors with symptoms like fatigue, dyspnoea, cognitive impairments, and more. The pathophysiology, risk factors, and treatments are still lacking in literature, but potential treatments may include rehabilitation training and repurposed drugs from similar conditions. Further research is needed to substantiate risk factors and treatment options.
INFECTIOUS DISEASES
(2021)
Review
Immunology
Ruitong Wang et al.
Summary: The study found that influenza vaccination is associated with a lower risk of SARS-CoV-2 infection, but not significantly associated with adverse outcomes. Influenza vaccination may have benefits for COVID-19 prevention.
Review
Immunology
Matthieu Van Tilbeurgh et al.
Summary: Vaccines represent a major advance in modern medicine, but continuous efforts are needed to design new vaccines to combat both existing and emerging pathogens. Identifying reliable predictive markers of immunogenicity can help in selecting and developing promising vaccine candidates, and the use of systems biology approaches with high-dimensional technologies and computational models is increasingly being adopted to address these challenges.
Article
Medicine, General & Internal
Giuseppe Lippi et al.
Summary: Although testing for anti-SARS-CoV-2 antibodies in recipients of COVID-19 vaccination can provide benefits such as assessing baseline seroprevalence, identifying non-responders, and detecting antibody decay, challenges like unclear equivalence between antibody titer, neutralizing activity, and vaccine efficiency; lack of cost-effective analyses; and increased laboratory workload remain. A potential solution involves prioritizing testing for high-risk individuals and those with lower vaccine immunogenicity.
Article
Psychology, Multidisciplinary
Annelise A. Madison et al.
Summary: Psychological factors can impact vaccine responses, with studies showing that stress, depression, loneliness, and poor health behaviors may weaken the immune system's response to vaccines, especially in vulnerable groups like the elderly. Intervention research suggests that psychological and behavioral interventions can increase vaccine efficacy during the COVID-19 pandemic.
PERSPECTIVES ON PSYCHOLOGICAL SCIENCE
(2021)
Article
Public, Environmental & Occupational Health
Jose F. Varona et al.
Summary: A study conducted in Spain found that the seroprevalence of SARS-CoV-2 antibodies among healthcare workers was slightly higher than in the general population and varied depending on regional COVID-19 incidence. High and moderate exposure risks were associated with positive IgG-SARS-CoV-2 antibodies, and older age and more severe disease were associated with higher antibody titres.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
(2021)
Editorial Material
Medicine, General & Internal
Lisa Rosenbaum
NEW ENGLAND JOURNAL OF MEDICINE
(2020)
Article
Microbiology
Fabrizio Bonelli et al.
JOURNAL OF CLINICAL MICROBIOLOGY
(2020)
Article
Biochemistry & Molecular Biology
Quan-Xin Long et al.
Article
Multidisciplinary Sciences
Jin-Wen Song et al.
NATURE COMMUNICATIONS
(2020)
Review
Medicine, General & Internal
Gregory A. Poland et al.
Article
Medicine, General & Internal
Brandon Michael Henry et al.
Article
Social Sciences, Mathematical Methods
Bobby L. Jones et al.
SOCIOLOGICAL METHODS & RESEARCH
(2007)
